NASDAQ: GILDGilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?
Insider buying vs selling
Have Gilead Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Harish Manwani | Director | 2026-04-30 | 224 | $130.84 | $29.31kSell |
| Daniel Patrick Oday | Chairman CEO | 2026-04-28 | 3,050 | $130.01 | $396.53kSell |
| Daniel Patrick Oday | Chairman CEO | 2026-04-28 | 6,950 | $128.79 | $895.08kSell |
| Andrew D. Dickinson | Chief Financial Officer | 2026-04-15 | 3,000 | $140.96 | $422.88kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-04-15 | 3,000 | $140.96 | $422.88kSell |
| Daniel Patrick Oday | Chairman CEO | 2026-03-27 | 10,000 | $136.82 | $1.37MSell |
| Andrew D. Dickinson | Chief Financial Officer | 2026-03-16 | 3,000 | $144.23 | $432.69kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-03-16 | 3,000 | $144.23 | $432.69kSell |
| Johanna Mercier | Chief Comm Corp Aff Officer | 2026-03-10 | 3,216 | $148.56 | $477.77kSell |
| Wettan Keeley M. Cain | EVP Gen Counsel Legal Comp | 2026-03-10 | 606 | $148.56 | $90.03kSell |
GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GILD insiders and whales buy or sell their stock.
GILD Shareholders
What type of owners hold Gilead Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 6.50% | 80,654,776 | $10.65B | Institution |
| Vanguard Portfolio Management LLC | 2.83% | 35,129,465 | $4.64B | Institution |
| Invesco Ltd | 1.25% | 15,526,336 | $2.05B | Institution |
| Bank Of New York Mellon Corp | 1.21% | 15,053,151 | $1.99B | Institution |
| Legal General Group PLC | 0.84% | 10,464,889 | $1.38B | Institution |
| Nuveen LLC | 0.63% | 7,833,564 | $1.03B | Institution |
| Dimensional Fund Advisors LP | 0.62% | 7,722,929 | $1.02B | Institution |
| Vanguard Fiduciary Trust Co | 0.57% | 7,032,718 | $928.74M | Institution |
| Wells Fargo Company | 0.53% | 6,628,441 | $875.35M | Institution |
| Deutsche Bank Ag | 0.50% | 6,222,328 | $821.72M | Institution |
GILD vs General Drug Manufacturer Stocks
Gilead Sciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.